APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Excipients for Oral Solid Dosage Forms

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Analysis and Forecast 2026-2032

23 December 2025203 pages

Choose your research edition.

Industry ResearchPharmaceutical Excipients for Oral Solid Dosage Forms Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Excipients for Oral Solid Dosage Forms market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pharmaceutical Excipients for Oral Solid Dosage Forms is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Excipients for Oral Solid Dosage Forms is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Excipients for Oral Solid Dosage Forms is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Excipients for Oral Solid Dosage Forms is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms include Ashland, Associated British Foods, BASF, Croda International, Dow, Evonik, JRS Pharma, Lubrizol and Mitsubishi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pharmaceutical Excipients for Oral Solid Dosage Forms, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Excipients for Oral Solid Dosage Forms, also provides the sales of main regions and countries. Of the upcoming market potential for Pharmaceutical Excipients for Oral Solid Dosage Forms, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Excipients for Oral Solid Dosage Forms sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Excipients for Oral Solid Dosage Forms market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Excipients for Oral Solid Dosage Forms sales, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Company

Ashland

Associated British Foods

BASF

Croda International

Dow

Evonik

JRS Pharma

Lubrizol

Mitsubishi

Roquette

Shin-Etsu

Südzucker AG

Hunan Er-Kang Pharmaceutical Co., Ltd.

Tianjin Chasesun Pharmaceutical Co., Ltd.

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

Sunrise Manufacture Group Co., Ltd.

Nanjing Well Pharmaceutical Group Co.,Ltd.

Xiwang Group

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Type

Fillers

Lubricants

Binders

Disintegrants

Coating Materials

Other

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Application

Tablets

Granules and Powders

Capsules

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipients for Oral Solid Dosage Forms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipients for Oral Solid Dosage Forms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipients for Oral Solid Dosage Forms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pharmaceutical Excipients for Oral Solid Dosage Forms in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Excipients for Oral Solid Dosage Forms manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Excipients for Oral Solid Dosage Forms sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fillers Major Manufacturers Table 3. Lubricants Major Manufacturers Table 4. Binders Major Manufacturers Table 5. Disintegrants Major Manufacturers Table 6. Coating Materials Major Manufacturers Table 7. Other Major Manufacturers Table 8. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Tablets Major Manufacturers Table 10. Granules and Powders Major Manufacturers Table 11. Capsules Major Manufacturers Table 12. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Trends Table 13. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Drivers Table 14. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Opportunities and Challenges Table 15. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Restraints Table 16. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2021-2026) Table 20. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2027-2032) Table 21. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 22. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2021-2026) & (t) Table 23. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2027-2032) & (t) Table 24. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Region (2021-2026) Table 25. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Region (2027-2032) Table 26. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Manufacturers (2021-2026) Table 30. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price (USD/t) of Manufacturers (2021-2026) Table 31. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers, Product Type & Application Table 34. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Pharmaceutical Excipients for Oral Solid Dosage Forms by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2026) Table 41. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2027-2032) Table 42. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type 2021 VS 2025 VS 2032 (t) Table 43. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 44. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 45. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2021-2026) Table 46. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2027-2032) Table 47. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2026) & (USD/t) Table 48. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2027-2032) & (USD/t) Table 49. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2021-2026) Table 53. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2027-2032) Table 54. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application 2021 VS 2025 VS 2032 (t) Table 55. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 56. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 57. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2021-2026) Table 58. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2027-2032) Table 59. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2026) & (USD/t) Table 60. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2027-2032) & (USD/t) Table 61. Ashland Company Information Table 62. Ashland Business Overview Table 63. Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 64. Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 65. Ashland Recent Development Table 66. Associated British Foods Company Information Table 67. Associated British Foods Business Overview Table 68. Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 70. Associated British Foods Recent Development Table 71. BASF Company Information Table 72. BASF Business Overview Table 73. BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 75. BASF Recent Development Table 76. Croda International Company Information Table 77. Croda International Business Overview Table 78. Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 80. Croda International Recent Development Table 81. Dow Company Information Table 82. Dow Business Overview Table 83. Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 85. Dow Recent Development Table 86. Evonik Company Information Table 87. Evonik Business Overview Table 88. Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 90. Evonik Recent Development Table 91. JRS Pharma Company Information Table 92. JRS Pharma Business Overview Table 93. JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 95. JRS Pharma Recent Development Table 96. Lubrizol Company Information Table 97. Lubrizol Business Overview Table 98. Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 100. Lubrizol Recent Development Table 101. Mitsubishi Company Information Table 102. Mitsubishi Business Overview Table 103. Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 105. Mitsubishi Recent Development Table 106. Roquette Company Information Table 107. Roquette Business Overview Table 108. Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 110. Roquette Recent Development Table 111. Shin-Etsu Company Information Table 112. Shin-Etsu Business Overview Table 113. Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 115. Shin-Etsu Recent Development Table 116. Südzucker AG Company Information Table 117. Südzucker AG Business Overview Table 118. Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 120. Südzucker AG Recent Development Table 121. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information Table 122. Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview Table 123. Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 125. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Development Table 126. Tianjin Chasesun Pharmaceutical Co., Ltd. Company Information Table 127. Tianjin Chasesun Pharmaceutical Co., Ltd. Business Overview Table 128. Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 130. Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Development Table 131. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Company Information Table 132. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Business Overview Table 133. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 135. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Recent Development Table 136. Sunrise Manufacture Group Co., Ltd. Company Information Table 137. Sunrise Manufacture Group Co., Ltd. Business Overview Table 138. Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 139. Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 140. Sunrise Manufacture Group Co., Ltd. Recent Development Table 141. Nanjing Well Pharmaceutical Group Co.,Ltd. Company Information Table 142. Nanjing Well Pharmaceutical Group Co.,Ltd. Business Overview Table 143. Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 144. Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 145. Nanjing Well Pharmaceutical Group Co.,Ltd. Recent Development Table 146. Xiwang Group Company Information Table 147. Xiwang Group Business Overview Table 148. Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 149. Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 150. Xiwang Group Recent Development Table 151. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 154. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 155. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2021-2026) & (USD/t) Table 156. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2027-2032) & (USD/t) Table 157. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2026) & (US$ Million) Table 158. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2027-2032) & (US$ Million) Table 159. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 160. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 161. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2021-2026) & (USD/t) Table 162. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2027-2032) & (USD/t) Table 163. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021 VS 2025 VS 2032) & (t) Table 167. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 168. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 169. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Country (2021-2026) & (USD/t) Table 170. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Country (2027-2032) & (USD/t) Table 171. United States Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 172. Canada Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 173. Mexico Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 174. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2026) & (US$ Million) Table 175. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2027-2032) & (US$ Million) Table 176. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 177. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 178. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2021-2026) & (USD/t) Table 179. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2027-2032) & (USD/t) Table 180. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2026) & (US$ Million) Table 181. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2027-2032) & (US$ Million) Table 182. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 183. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 184. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2021-2026) & (USD/t) Table 185. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2027-2032) & (USD/t) Table 186. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021 VS 2025 VS 2032) & (t) Table 190. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 191. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 192. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Country (2021-2026) & (USD/t) Table 193. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Country (2027-2032) & (USD/t) Table 194. Germany Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 195. France Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 196. U.K. Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 197. Italy Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 198. Russia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 199. Spain Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 200. Netherlands Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 201. Switzerland Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 202. Sweden Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 203. Poland Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 204. China Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2026) & (US$ Million) Table 205. China Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2027-2032) & (US$ Million) Table 206. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 207. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 208. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2021-2026) & (USD/t) Table 209. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2027-2032) & (USD/t) Table 210. China Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2026) & (US$ Million) Table 211. China Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2027-2032) & (US$ Million) Table 212. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 213. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 214. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2021-2026) & (USD/t) Table 215. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2027-2032) & (USD/t) Table 216. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2026) & (US$ Million) Table 217. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2027-2032) & (US$ Million) Table 218. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 219. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 220. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2021-2026) & (USD/t) Table 221. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2027-2032) & (USD/t) Table 222. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2026) & (US$ Million) Table 223. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2027-2032) & (US$ Million) Table 224. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 225. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 226. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2021-2026) & (USD/t) Table 227. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2027-2032) & (USD/t) Table 228. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021 VS 2025 VS 2032) & (t) Table 232. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 233. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 234. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Country (2021-2026) & (USD/t) Table 235. Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Country (2027-2032) & (USD/t) Table 236. Japan Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 237. South Korea Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 238. India Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 239. Australia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 240. Taiwan Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 245. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 246. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2021-2026) & (USD/t) Table 247. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Type (2027-2032) & (USD/t) Table 248. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2026) & (US$ Million) Table 249. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2027-2032) & (US$ Million) Table 250. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 251. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 252. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2021-2026) & (USD/t) Table 253. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Application (2027-2032) & (USD/t) Table 254. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021 VS 2025 VS 2032) & (t) Table 258. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 259. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 260. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Country (2021-2026) & (USD/t) Table 261. SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Country (2027-2032) & (USD/t) Table 262. Brazil Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 263. Argentina Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 264. Chile Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 265. Colombia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 266. Peru Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 268. Israel Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 269. UAE Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 270. Turkey Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 271. Iran Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 272. Egypt Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Pharmaceutical Excipients for Oral Solid Dosage Forms Distributors List Table 276. Pharmaceutical Excipients for Oral Solid Dosage Forms Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Pharmaceutical Excipients for Oral Solid Dosage Forms Image Figure 2. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fillers Image Figure 5. Lubricants Image Figure 6. Binders Image Figure 7. Disintegrants Image Figure 8. Coating Materials Image Figure 9. Other Image Figure 10. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Share 2021 VS 2025 VS 2032 Figure 12. Tablets Image Figure 13. Granules and Powders Image Figure 14. Capsules Image Figure 15. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Figure 17. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2021-2032) Figure 20. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (2021-2032) & (t) Figure 21. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 22. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Pharmaceutical Excipients for Oral Solid Dosage Forms Sales YoY (2021-2032) & (t) Figure 24. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales YoY (2021-2032) & (t) Figure 25. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales YoY (2021-2032) & (t) Figure 26. Asia (Excluding China) Pharmaceutical Excipients for Oral Solid Dosage Forms Sales YoY (2021-2032) & (t) Figure 27. South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales YoY (2021-2032) & (t) Figure 28. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2032) Figure 34. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021 VS 2025 VS 2032) & (t

Scope & coverage.

Types
  • Fillers
  • Lubricants
  • Binders
  • Disintegrants
  • Coating Materials
  • Other
Applications
  • Tablets
  • Granules and Powders
  • Capsules
Companies covered
  • Ashland
  • Associated British Foods
  • BASF
  • Croda International
  • Dow
  • Evonik
  • JRS Pharma
  • Lubrizol
  • Mitsubishi
  • Roquette
  • Shin-Etsu
  • Südzucker AG
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Tianjin Chasesun Pharmaceutical Co., Ltd.
  • Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
  • Sunrise Manufacture Group Co., Ltd.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.
  • Xiwang Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Type
  3. 1.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fillers
  5. 1.2.3 Lubricants
  6. 1.2.4 Binders
  7. 1.2.5 Disintegrants
  8. 1.2.6 Coating Materials
  9. 1.2.7 Other
  10. 1.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Application
  11. 1.3.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Tablets
  13. 1.3.3 Granules and Powders
  14. 1.3.4 Capsules
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Pharmaceutical Excipients for Oral Solid Dosage Forms Market Dynamics
  1. 2.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Trends
  2. 2.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Drivers
  3. 2.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region
  3. 3.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2027-2032)
  6. 3.2.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region
  9. 3.4.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2021-2026)
  11. 3.4.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2027-2032)
  12. 3.4.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Manufacturers
  2. 4.1.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Manufacturers
  6. 4.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers, Product Type & Application
  13. 4.7 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market CR5 and HHI
  16. 4.8.2 2025 Pharmaceutical Excipients for Oral Solid Dosage Forms Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Type
  1. 5.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type
  2. 5.1.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type
  6. 5.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032) & (t)
  8. 5.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type
6 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Application
  1. 6.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application
  2. 6.1.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application
  6. 6.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032) & (t)
  8. 6.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application
7 Company Profiles
  1. 7.1 Ashland
  2. 7.1.1 Ashland Company Information
  3. 7.1.2 Ashland Business Overview
  4. 7.1.3 Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  6. 7.1.5 Ashland Recent Developments
  7. 7.2 Associated British Foods
  8. 7.2.1 Associated British Foods Company Information
  9. 7.2.2 Associated British Foods Business Overview
  10. 7.2.3 Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  12. 7.2.5 Associated British Foods Recent Developments
  13. 7.3 BASF
  14. 7.3.1 BASF Company Information
  15. 7.3.2 BASF Business Overview
  16. 7.3.3 BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  18. 7.3.5 BASF Recent Developments
  19. 7.4 Croda International
  20. 7.4.1 Croda International Company Information
  21. 7.4.2 Croda International Business Overview
  22. 7.4.3 Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  24. 7.4.5 Croda International Recent Developments
  25. 7.5 Dow
  26. 7.5.1 Dow Company Information
  27. 7.5.2 Dow Business Overview
  28. 7.5.3 Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  30. 7.5.5 Dow Recent Developments
  31. 7.6 Evonik
  32. 7.6.1 Evonik Company Information
  33. 7.6.2 Evonik Business Overview
  34. 7.6.3 Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  36. 7.6.5 Evonik Recent Developments
  37. 7.7 JRS Pharma
  38. 7.7.1 JRS Pharma Company Information
  39. 7.7.2 JRS Pharma Business Overview
  40. 7.7.3 JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  42. 7.7.5 JRS Pharma Recent Developments
  43. 7.8 Lubrizol
  44. 7.8.1 Lubrizol Company Information
  45. 7.8.2 Lubrizol Business Overview
  46. 7.8.3 Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  48. 7.8.5 Lubrizol Recent Developments
  49. 7.9 Mitsubishi
  50. 7.9.1 Mitsubishi Company Information
  51. 7.9.2 Mitsubishi Business Overview
  52. 7.9.3 Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  54. 7.9.5 Mitsubishi Recent Developments
  55. 7.10 Roquette
  56. 7.10.1 Roquette Company Information
  57. 7.10.2 Roquette Business Overview
  58. 7.10.3 Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  60. 7.10.5 Roquette Recent Developments
  61. 7.11 Shin-Etsu
  62. 7.11.1 Shin-Etsu Company Information
  63. 7.11.2 Shin-Etsu Business Overview
  64. 7.11.3 Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  66. 7.11.5 Shin-Etsu Recent Developments
  67. 7.12 Südzucker AG
  68. 7.12.1 Südzucker AG Company Information
  69. 7.12.2 Südzucker AG Business Overview
  70. 7.12.3 Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  72. 7.12.5 Südzucker AG Recent Developments
  73. 7.13 Hunan Er-Kang Pharmaceutical Co., Ltd.
  74. 7.13.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information
  75. 7.13.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
  76. 7.13.3 Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  78. 7.13.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments
  79. 7.14 Tianjin Chasesun Pharmaceutical Co., Ltd.
  80. 7.14.1 Tianjin Chasesun Pharmaceutical Co., Ltd. Company Information
  81. 7.14.2 Tianjin Chasesun Pharmaceutical Co., Ltd. Business Overview
  82. 7.14.3 Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  84. 7.14.5 Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Developments
  85. 7.15 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
  86. 7.15.1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Company Information
  87. 7.15.2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Business Overview
  88. 7.15.3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  90. 7.15.5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Recent Developments
  91. 7.16 Sunrise Manufacture Group Co., Ltd.
  92. 7.16.1 Sunrise Manufacture Group Co., Ltd. Company Information
  93. 7.16.2 Sunrise Manufacture Group Co., Ltd. Business Overview
  94. 7.16.3 Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  96. 7.16.5 Sunrise Manufacture Group Co., Ltd. Recent Developments
  97. 7.17 Nanjing Well Pharmaceutical Group Co.,Ltd.
  98. 7.17.1 Nanjing Well Pharmaceutical Group Co.,Ltd. Company Information
  99. 7.17.2 Nanjing Well Pharmaceutical Group Co.,Ltd. Business Overview
  100. 7.17.3 Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  102. 7.17.5 Nanjing Well Pharmaceutical Group Co.,Ltd. Recent Developments
  103. 7.18 Xiwang Group
  104. 7.18.1 Xiwang Group Company Information
  105. 7.18.2 Xiwang Group Business Overview
  106. 7.18.3 Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  108. 7.18.5 Xiwang Group Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Type
  2. 8.1.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2032)
  3. 8.1.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032)
  4. 8.1.3 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2032)
  5. 8.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Application
  6. 8.2.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2032)
  7. 8.2.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032)
  8. 8.2.3 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2032)
  9. 8.3 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  10. 8.3.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Type
  2. 9.1.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032)
  4. 9.1.3 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2032)
  5. 9.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Application
  6. 9.2.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032)
  8. 9.2.3 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2032)
  9. 9.3 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  10. 9.3.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Type
  2. 10.1.1 China Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2032)
  3. 10.1.2 China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032)
  4. 10.1.3 China Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2032)
  5. 10.2 China Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Application
  6. 10.2.1 China Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2032)
  7. 10.2.2 China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032)
  8. 10.2.3 China Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Type
  2. 11.1.1 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032)
  4. 11.1.3 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2032)
  5. 11.2 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Application
  6. 11.2.1 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032)
  8. 11.2.3 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2032)
  9. 11.3 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  10. 11.3.1 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Type
  2. 12.1.1 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2032)
  5. 12.2 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Application
  6. 12.2.1 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2032)
  9. 12.3 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  10. 12.3.1 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Value Chain Analysis
  2. 13.1.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pharmaceutical Excipients for Oral Solid Dosage Forms Production Mode & Process
  6. 13.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Distributors
  9. 13.2.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst